Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-23T02:24:48.311Z Has data issue: false hasContentIssue false
  • English
  • Français

Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity

Published online by Cambridge University Press:  22 July 2019

C. van der Leeuw Open the ORCID record for C. van der Leeuw [Opens in a new window] ,
L. D. de Witte ,
A. Stellinga ,
C. van der Ley ,
R. Bruggeman ,
R. S. Kahn ,
J. van Os ,
M. Marcelis  and
for G.R.O.U.P.
C. van der Leeuw*
Affiliation:
Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands Mondriaan, Maastricht, the Netherlands
L. D. de Witte
Affiliation:
Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
A. Stellinga
Affiliation:
Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands University Center for Psychiatry, Rob Giel Research Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
C. van der Ley
Affiliation:
Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
R. Bruggeman
Affiliation:
University Center for Psychiatry, Rob Giel Research Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
R. S. Kahn
Affiliation:
Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
J. van Os
Affiliation:
Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
M. Marcelis
Affiliation:
Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands Institute for Mental Health Care Eindhoven (GGzE), Eindhoven, the Netherlands
*
Author for correspondence: C. van der Leeuw, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The association between schizophrenia and decreased vitamin D levels is well documented. Low maternal and postnatal vitamin D levels suggest a possible etiological mechanism. Alternatively, vitamin D deficiency in patients with schizophrenia is presumably (also) the result of disease-related factors or demographic risk factors such as urbanicity.

Methods

In a study population of 347 patients with psychotic disorder and 282 controls, group differences in vitamin D concentration were examined. Within the patient group, associations between vitamin D, symptom levels and clinical variables were analyzed. Group × urbanicity interactions in the model of vitamin D concentration were examined. Both current urbanicity and urbanicity at birth were assessed.

Results

Vitamin D concentrations were significantly lower in patients (B = −8.05; 95% confidence interval (CI) −13.68 to −2.42; p = 0.005). In patients, higher vitamin D concentration was associated with lower positive (B = −0.02; 95% CI −0.04 to 0.00; p = 0.049) and negative symptom levels (B = −0.03; 95% CI −0.05 to −0.01; p = 0.008). Group differences were moderated by urbanicity at birth (χ2 = 6.76 and p = 0.001), but not by current urbanicity (χ2 = 1.50 and p = 0.224). Urbanicity at birth was negatively associated with vitamin D concentration in patients (B = −5.11; 95% CI −9.41 to −0.81; p = 0.020), but not in controls (B = 0.72; 95% CI −4.02 to 5.46; p = 0.765).

Conclusions

Lower vitamin D levels in patients with psychotic disorder may in part reflect the effect of psychosis risk mediated by early environmental adversity. The data also suggest that lower vitamin D and psychopathology may be related through direct or indirect mechanisms.

Keywords

Psychotic disorderschizophreniaurbanicityvitamin D
Type
Original Articles
Information
Psychological Medicine , Volume 50 , Issue 10 , July 2020 , pp. 1680 - 1686
Copyright
Copyright © Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Membership of G.R.O.U.P. is provided in the Acknowledgements.

References

Adamson, J, Lally, J, Gaughran, F, Krivoy, A, Allen, L and Stubbs, B (2017) Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Research 249, 78–85.CrossRefGoogle ScholarPubMed
American Geriatric Society Workgroup on Vitamin D Supplementation for Older Adults (2014) Recommendations abstracted from the American geriatrics society consensus statement on vitamin D for prevention of falls and their consequences. Journal of the American Geriatric Society 62, 147–152.CrossRefGoogle Scholar
Andreasen, NC, Flaum, M and Arndt, S (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615–623.CrossRefGoogle ScholarPubMed
Belvederi Murri, M, Respino, M, Masotti, M, Innamorati, M, Mondelli, V, Pariante, C and Amore, M (2013) Vitamin D and psychosis: mini meta-analysis. Schizophrenia Research 150, 235–239.CrossRefGoogle ScholarPubMed
Berg, AO, Melle, I, Torjesen, PA, Lien, L, Hauff, E and Andreassen, OA (2010) A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. Journal of Clinical Psychiatry 71, 1598–1604.CrossRefGoogle ScholarPubMed
Berg, AO, Jorgensen, KN, Nerhus, M, Athanasiu, L, Popejoy, AB, Bettella, F, Norbom, LCB, Gurholt, TP, Dahl, SR, Andreassen, OA, Djurovic, S, Agartz, I and Melle, I (2018) Vitamin D levels, brain volume, and genetic architecture in patients with psychosis. PLoS One 13, e0200250.CrossRefGoogle ScholarPubMed
Boerman, R, Cohen, D, Schulte, PF and Nugter, A (2016) Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia. Journal of Clinical Psychopharmacology 36, 588–592.CrossRefGoogle ScholarPubMed
Bruins, J, Jorg, F, van den Heuvel, ER, Bartels-Velthuis, AA, Corpeleijn, E, Muskiet, FAJ, Pijnenborg, GHM and Bruggeman, R (2017) The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders. Schizophrenia Research 195, 513–518.CrossRefGoogle ScholarPubMed
Cantor-Graae, E and Selten, JP (2005) Schizophrenia and migration: a meta-analysis and review. American Journal of Psychiatry 162, 12–24.CrossRefGoogle ScholarPubMed
Clayton, D and Hills, M (1993) Statistical Models in Epidemiology. Oxford: Oxford University Press.Google Scholar
Crews, M, Lally, J, Gardner-Sood, P, Howes, O, Bonaccorso, S, Smith, S, Murray, RM, Di Forti, M and Gaughran, F (2013) Vitamin D deficiency in first episode psychosis: a case-control study. Schizophrenia Research 150, 533–537.CrossRefGoogle ScholarPubMed
Davies, G, Welham, J, Chant, D, Torrey, EF and McGrath, J (2003) A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophrenia Bulletin 29, 587–593.CrossRefGoogle Scholar
Dealberto, MJ (2007) Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Medical Hypotheses 68, 259–267.CrossRefGoogle ScholarPubMed
Dealberto, MJ (2010) Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent and longstanding immigration. Acta Psychiatrica Scandinavica 121, 325–339.CrossRefGoogle ScholarPubMed
Dealberto, MJ (2013) Clinical symptoms of psychotic episodes and 25-hydroxy vitamin D serum levels in black first-generation immigrants. Acta Psychiatrica Scandinavica 128, 475–487.CrossRefGoogle ScholarPubMed
DeLuca, GC, Kimball, SM, Kolasinski, J, Ramagopalan, SV and Ebers, GC (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathology and Applied Neurobiology 39, 458–484.CrossRefGoogle ScholarPubMed
Eyles, D, Burne, T and McGrath, J (2011) Vitamin D in fetal brain development. Seminars in Cell and Developmental Biology 22, 629–636.CrossRefGoogle ScholarPubMed
Eyles, DW, Burne, TH and McGrath, JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology 34, 47–64.CrossRefGoogle ScholarPubMed
Eyles, DW, Trzaskowski, M, Vinkhuyzen, AAE, Mattheisen, M, Meier, S, Gooch, H, Anggono, V, Cui, X, Tan, MC, Burne, THJ, Jang, SE, Kvaskoff, D, Hougaard, DM, Norgaard-Pedersen, B, Cohen, A, Agerbo, E, Pedersen, CB, Borglum, AD, Mors, O, Sah, P, Wray, NR, Mortensen, PB and McGrath, JJ (2018) The association between neonatal vitamin D status and risk of schizophrenia. Scientific Reports 8, 17692.CrossRefGoogle ScholarPubMed
Firth, J, Carney, R, Stubbs, B, Teasdale, SB, Vancampfort, D, Ward, PB, Berk, M and Sarris, J (2017) Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophrenia Bulletin 44, 1275–1292.CrossRefGoogle Scholar
Frissen, A, Lieverse, R, Drukker, M, van Winkel, R, Delespaul, P and for GROUP (2015) Childhood trauma and childhood urbanicity in relation to psychotic disorder. Social Psychiatry and Psychiatric Epidemiology 50, 1481–1488.CrossRefGoogle ScholarPubMed
Frissen, A, van Os, J, Habets, P, Gronenschild, E, Marcelis, M and for GROUP (2017) No evidence of association between childhood urban environment and cortical thinning in psychotic disorder. PLoS One 12, e0166651.CrossRefGoogle ScholarPubMed
Gomez, L, Stubbs, B, Shirazi, A, Vancampfort, D, Gaughran, F and Lally, J (2016) Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis. Current Osteoporosis Reports 14, 249–259.CrossRefGoogle ScholarPubMed
Graham, KA, Keefe, RS, Lieberman, JA, Calikoglu, AS, Lansing, KM and Perkins, DO (2015) Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Intervention in Psychiatry 9, 397–405.CrossRefGoogle ScholarPubMed
Hedelin, M, Lof, M, Olsson, M, Lewander, T, Nilsson, B, Hultman, CM and Weiderpass, E (2010) Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33000 women from the general population. BMC Psychiatry 10, 38.CrossRefGoogle Scholar
Humble, MB (2010) Vitamin D, light and mental health. Journal of Photochemistry and Photobiology B 101, 142–149.CrossRefGoogle ScholarPubMed
Humble, MB, Gustafsson, S and Bejerot, S (2010) Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. Journal of Steroid Biochemistry and Molecular Biology 121, 467–470.CrossRefGoogle ScholarPubMed
Itzhaky, D, Amital, D, Gorden, K, Bogomolni, A, Arnson, Y and Amital, H (2012) Low serum vitamin D concentrations in patients with schizophrenia. Israel Medical Association Journal 14, 88–92.Google ScholarPubMed
Ju, SY, Lee, YJ and Jeong, SN (2013) Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. Journal of Nutrition, Health and Aging 17, 447–455.CrossRefGoogle ScholarPubMed
Kay, SR, Fiszbein, A and Opler, LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.CrossRefGoogle Scholar
Kinney, DK, Teixeira, P, Hsu, D, Napoleon, SC, Crowley, DJ, Miller, A, Hyman, W and Huang, E (2009) Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophrenia Bulletin 35, 582–595.CrossRefGoogle ScholarPubMed
Kirkbride, JB and Jones, PB (2011) The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophrenia Bulletin 37, 262–271.CrossRefGoogle ScholarPubMed
Korver, N, Quee, PJ, Boos, HB, Simons, CJ, de Haan, L and for GROUP (2012) Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. International Journal of Methods in Psychiatric Research 21, 205–221.CrossRefGoogle ScholarPubMed
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A and Weizman, A (2017) Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial. EBioMedicine 26, 138–145.CrossRefGoogle ScholarPubMed
Lally, J, Gardner-Sood, P, Firdosi, M, Iyegbe, C, Stubbs, B, Greenwood, K, Murray, R, Smith, S, Howes, O and Gaughran, F (2016) Clinical correlates of vitamin D deficiency in established psychosis. BMC Psychiatry 16, 76.CrossRefGoogle ScholarPubMed
Lippi, G, Bonelli, P, Buonocore, R and Aloe, R (2015) Birth season and vitamin D concentration in adulthood. Annals of Translational Medicine 3, 231.Google ScholarPubMed
McGrath, J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophrenia Research 40, 173–177.CrossRefGoogle Scholar
McGrath, J, Eyles, D, Mowry, B, Yolken, R and Buka, S (2003) Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophrenia Research 63, 73–78.CrossRefGoogle ScholarPubMed
McGrath, JJ, Eyles, DW, Pedersen, CB, Anderson, C, Ko, P, Burne, TH, Norgaard-Pedersen, B, Hougaard, DM and Mortensen, PB (2010) Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Archives of General Psychiatry 67, 889–894.CrossRefGoogle ScholarPubMed
Mendes, MM, Darling, AL, Hart, KH, Morse, S, Murphy, RJ and Lanham-New, SA (2019) Impact of high latitude, urban living and ethnicity on 25-hydroxyvitamin D status: a need for multidisciplinary action? The Journal of Steroid Biochemistry and Molecular Biology 188, 95–102.CrossRefGoogle ScholarPubMed
Menkes, DB, Lancaster, K, Grant, M, Marsh, RW, Dean, P and du Toit, SA (2012) Vitamin D status of psychiatric inpatients in New Zealand's Waikato region. BMC Psychiatry 12, 68.CrossRefGoogle ScholarPubMed
Nerhus, M, Berg, AO, Dahl, SR, Holvik, K, Gardsjord, ES, Weibell, MA, Bjella, TD, Andreassen, OA and Melle, I (2015) Vitamin D status in psychotic disorder patients and healthy controls--The influence of ethnic background. Psychiatry Research 230, 616–621.CrossRefGoogle ScholarPubMed
Nerhus, M, Berg, AO, Kvitland, LR, Dieset, I, Hope, S, Dahl, SR, Weibell, MA, Romm, KL, Faerden, A, Andreassen, OA and Melle, I (2016) Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophrenia Research 178, 44–49.CrossRefGoogle ScholarPubMed
Partti, K, Heliovaara, M, Impivaara, O, Perala, J, Saarni, SI, Lonnqvist, J and Suvisaari, JM (2010) Skeletal status in psychotic disorders: a population-based study. Psychosomatic Medicine 72, 933–940.CrossRefGoogle ScholarPubMed
Pedersen, CB and Mortensen, PB (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Archives of General Psychiatry 58, 1039–1046.CrossRefGoogle ScholarPubMed
Reininghaus, U, Dutta, R, Dazzan, P, Doody, GA, Fearon, P, Lappin, J, Heslin, M, Onyejiaka, A, Donoghue, K, Lomas, B, Kirkbride, JB, Murray, RM, Croudace, T, Morgan, C and Jones, PB (2015) Mortality in schizophrenia and other psychoses: a 10-year follow-up of the SOP first-episode cohort. Schizophrenia Bulletin 41, 664–673.CrossRefGoogle ScholarPubMed
Saha, S, Chant, DC, Welham, JL and McGrath, JJ (2006) The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica Scandinavica 114, 36–39.CrossRefGoogle ScholarPubMed
Salavert, J, Grados, D, Ramiro, N, Carrion, MI, Fadeuilhe, C, Palma, F, Lopez, L, Erra, A and Ramirez, N (2017) Association between vitamin D Status and schizophrenia: a first psychotic episode study. Journal of Nervous and Mental Disease 205, 409–412.CrossRefGoogle ScholarPubMed
Suetani, S, Saha, S, Eyles, DW, Scott, JG and McGrath, JJ (2017) Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry 51, 921–929.CrossRefGoogle ScholarPubMed
Sullivan, S, Wills, A, Lawlor, D, McGrath, J and Zammit, S (2013) Prenatal vitamin D status and risk of psychotic experiences at age 18years-a longitudinal birth cohort. Schizophrenia Research 148, 87–92.CrossRefGoogle ScholarPubMed
Taylor, AE, Burgess, S, Ware, JJ, Gage, SH, Richards, JB, Davey Smith, G and Munafo, MR (2016) Investigating causality in the association between 25(OH)D and schizophrenia. Scientific Reports 6, 26496.CrossRefGoogle Scholar
Valipour, G, Saneei, P and Esmaillzadeh, A (2014) Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. Journal of Clinical Endocrinology and Metabolism 99, 3863–3872.CrossRefGoogle ScholarPubMed
van Mierlo, HC, de Witte, L, Derksen, RH, Otten, HG and for GROUP (2015) The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study. NPJ Schizophrenia 1, 15013.CrossRefGoogle ScholarPubMed
Veling, W, Hoek, HW, Selten, JP and Susser, E (2011) Age at migration and future risk of psychotic disorders among immigrants in the Netherlands: a 7-year incidence study. American Journal of Psychiatry 168, 1278–1285.CrossRefGoogle ScholarPubMed
Yee, JY, See, YM, Abdul Rashid, NA, Neelamekam, S and Lee, J (2016) Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis. Psychiatry Research 243, 390–394.CrossRefGoogle ScholarPubMed
Yoo, T, Choi, W, Hong, JH, Lee, JY, Kim, JM, Shin, IS, Yang, SJ, Amminger, P, Berk, M, Yoon, JS and Kim, SW (2018) Association between vitamin D insufficiency and metabolic syndrome in patients with psychotic disorders. Psychiatry Investigation 15, 396–401.CrossRefGoogle ScholarPubMed
Yuksel, RN, Altunsoy, N, Tikir, B, Cingi Kuluk, M, Unal, K, Goka, S, Aydemir, C and Goka, E (2014) Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Therapeutic Advances in Psychopharmacology 4, 268–275.CrossRefGoogle ScholarPubMed
Zhu, DM, Liu, Y, Zhang, AG, Chu, ZX, Wu, Q, Li, H, Ge, JF, Dong, Y and Zhu, P (2015) High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein. Psychiatry Research 228, 565–570.CrossRefGoogle ScholarPubMed